Company profile: Jupiter Endovascular
1.1 - Company Overview
Company description
- Provider of endovascular medical technologies, including the Vertex Pulmonary Embolectomy System to treat acute pulmonary embolism with enhanced control and precision, and Endoportal Control, a platform that enhances catheter interventions by providing stability and control for access to difficult anatomical sites.
Products and services
- Endoportal Control: A catheter-based platform that enhances catheter interventions by delivering stability and control, allowing access to difficult anatomical sites during challenging procedures
- Vertex Pulmonary Embolectomy System: An endovascular-grade system designed to treat acute pulmonary embolism by providing enhanced control and precision during endovascular procedures
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Jupiter Endovascular
NovaCardia
HQ: United States
Website
- Description: Provider of cardiovascular drug development and commercialization of novel small molecule drugs to improve care for patients with cardiovascular disease; a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NovaCardia company profile →
Recovery Force
HQ: United States
Website
- Description: Provider of MORPH, an on-body pre recovery and performance enhancement system, developed and manufactured by Recovery Force.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Recovery Force company profile →
Angiodroid
HQ: Italy
Website
- Description: Provider of automatic carbon dioxide angiography solutions for hemodynamics, vascular surgery, and interventional radiology, including Angiodroid The CO2 Injector for peripheral diagnostic and interventional procedures, the Angiodroid Easy Kit disposable accessories, ANGIOPULSE counterpulsation weaning console, and the ACDA Academy offering training, articles, conferences, and live case streaming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Angiodroid company profile →
Reprieve Cardiovascular
HQ: United States
Website
- Description: Provider of personalized decongestion and automated fluid management for acute decompensated heart failure, offering the Reprieve System, Personalized Volume Management System, and Guided Diuretic Therapy to tailor diuretic dosing, speed fluid removal and symptom relief, prevent hypotension, maintain renal function, and reduce readmissions; also conducting the FASTR trial comparing Reprieve therapy to optimized diuretics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reprieve Cardiovascular company profile →
Intelesens
HQ: United Kingdom
Website
- Description: Provider of intelligent, wearable, non-invasive, wireless vital signs monitoring devices for hospital and home patient monitoring, leveraging proprietary high-sensitivity arrhythmia and respiratory algorithms, and offering defibrillation and ECG electrodes plus custom electrode design, prototyping, and end-to-end manufacturing compliant with international regulatory standards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intelesens company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Jupiter Endovascular
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Jupiter Endovascular
2.2 - Growth funds investing in similar companies to Jupiter Endovascular
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Jupiter Endovascular
4.2 - Public trading comparable groups for Jupiter Endovascular
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →